Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Published

Journal Article

Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine screening, and treatment of precancerous lesions. However, due to inadequate screening protocols in many regions of the world, cervical cancer remains the fourth-most common cancer in women globally. The complete NCCN Guidelines for Cervical Cancer provide recommendations for the diagnosis, evaluation, and treatment of cervical cancer. This manuscript discusses guiding principles for the workup, staging, and treatment of early stage and locally advanced cervical cancer, as well as evidence for these recommendations. For recommendations regarding treatment of recurrent or metastatic disease, please see the full guidelines on NCCN.org.

Full Text

Duke Authors

Cited Authors

  • Koh, W-J; Abu-Rustum, NR; Bean, S; Bradley, K; Campos, SM; Cho, KR; Chon, HS; Chu, C; Clark, R; Cohn, D; Crispens, MA; Damast, S; Dorigo, O; Eifel, PJ; Fisher, CM; Frederick, P; Gaffney, DK; Han, E; Huh, WK; Lurain, JR; Mariani, A; Mutch, D; Nagel, C; Nekhlyudov, L; Fader, AN; Remmenga, SW; Reynolds, RK; Tillmanns, T; Ueda, S; Wyse, E; Yashar, CM; McMillian, NR; Scavone, JL

Published Date

  • January 2019

Published In

Volume / Issue

  • 17 / 1

Start / End Page

  • 64 - 84

PubMed ID

  • 30659131

Pubmed Central ID

  • 30659131

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2019.0001

Language

  • eng

Conference Location

  • United States